Company Information
USD
3.01
- (-3.2%)
NASDAQ:RCKT, ROCKET PHARMACEUTICALS, INC.
Industry: Biotechnology
End of Day: 29 July 2025 GMT-4
Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis.
Address
9 Cedarbrook Drive
Website
Classification
Sector
Healthcare
Industry Group
Biotechnology
Industry
Biotechnology
Key Executives
Mr. Jonathan Schwartz
Other Executive Officer
Mr. R. Keith Woods
Director
Mr. Mark White
Chief Medical Officer
Mr. Carsten Boess
Director
Mr. Pedro P. Granadillo
Director
Mr. David P. Southwell
Director
Dr. Roderick Wong, M.D.
Chairman of the Board/Director
Dr. Fady Ibraham Malik, M.D.,PhD
Director
Mr. John Militello, C.P.A.
CFO/Chief Accounting Officer/Treasurer/Vice President, Divisional
Mr. Martin Wilson
Chief Compliance Officer/General Counsel/Senior VP
Dr. Gaurav Shah, M.D.
CEO/Director
Dr. Naveen Yalamanchi, M.D.
Director
Dr. Gotham Makker, M.D.
Director
Dr. Kinnari Patel
COO/President
Dr. Elisabeth Bjork, M.D.,PhD
Director
Mr. Raj Prabhakar
Other Executive Officer/Senior VP
Mr. Mayo Pujols
Chief Technology Officer/Executive VP
Ownership
Institution Holdings
RTW Investments, LP
18,157,605 (20.140%)
RTW INVESTMENTS, LLC
17,687,772 (19.544%)
Wellington Management Group, LLP
8,197,546 (9.092%)
Wellington Management Company LLP
8,197,546 (9.058%)
BlackRock Inc
5,930,178 (6.552%)
Vanguard Group Inc
5,447,565 (6.019%)
Maverick Capital Ltd
4,034,068 (4.457%)
Westfield Capital Management Company, LP
3,941,859 (4.355%)
State Street Corporation
3,231,411 (3.570%)
BlackRock Fund Advisors
2,879,822 (3.182%)
Funds Holdings
Vanguard US Total Market Shares ETF
2,214,331 (2.447%)
Vanguard Total Stock Market Index Fund
2,214,331 (2.447%)
SPDR® S&P Biotech ETF
1,957,849 (2.163%)
iShares Russell 2000 ETF
1,538,082 (1.699%)
Vanguard Institutional Extnd Mkt Idx Tr
1,033,841 (1.142%)
Vanguard Small Cap Index
863,258 (0.954%)
T. Rowe Price Health Sciences Fund
854,454 (0.944%)
US Small-Cap Growth II Equity Comp
854,016 (0.944%)
T. Rowe Price New Horizons Fund
854,016 (0.944%)
Putnam Global Health Care Fund
797,600 (0.881%)
Make Smart Investment Choices